iodosorb
smith & nephew ltd - cadexomer iodine 60%{relative} - medicated dressing - 600 mg/g - active: cadexomer iodine 60%{relative} excipient: macrogol 1500 macrogol 300
iodosorb cadexomer iodine 500mg/g medicated ointment
smith & nephew ltd - cadexomer iodine 50%{relative} - topical ointment - 500 mg/g - active: cadexomer iodine 50%{relative} excipient: macrogol 400 macrogol 4000 poloxamer
koate-dvi for injection 1000 iu10 ml
grifols asia pacific pte. ltd. - antihemophilic factor (human) (factor viii) - injection, powder, for solution - min 800 iu/10 ml - antihemophilic factor (human) (factor viii) min 800 iu/10 ml
koate-dvi for injection 250 iu5 ml
grifols asia pacific pte. ltd. - antihemophilic factor (human) (factor viii) - injection, powder, for solution - min 250 iu/5 ml - antihemophilic factor (human) (factor viii) min 250 iu/5 ml
koate-dvi for injection 500 iu5 ml
grifols asia pacific pte. ltd. - antihemophilic factor (human) (factor viii) - injection, powder, for solution - min 400 iu/5 ml - antihemophilic factor (human) (factor viii) min 400 iu/5 ml
iodosorb dressing n/a
al zahrawi medicines trading sweden - 5's [ 5 pouches 5g/ 6cm x 4cm] 66001290 - dressing - n/a - medical devices-medical devices
medicinsk oxygen nippon gases scandinavia 100 % medicinsk gas, kryogen
koate dvi 250
padagis israel agencies ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 250 iu/vial - coagulation factor viii - coagulation factor viii - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor viii . koate-dvi provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.
koate dvi 500
padagis israel agencies ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 500 iu/vial - coagulation factor viii - coagulation factor viii - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor viii . koate-dvi provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.
koate dvi 1000
padagis israel agencies ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 1000 iu/vial - coagulation factor viii - coagulation factor viii - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor viii . koate-dvi provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.